Compound information
- Natural Products
- ZC2583557
- Molecular Formula
- C19H21Cl2N3O2
- Molecular Weight
- 393.101082272 g/mol
- Structure
-
- IUPAC Name
- N-(2,4-dichlorophenyl)-4-[(3-methoxyphenyl)methyl]piperazine-1-carboxamide
- InChI
- InChI=1S/C19H21Cl2N3O2/c1-26-16-4-2-3-14(11-16)13-23-7-9-24(10-8-23)19(25)22-18-6-5-15(20)12-17(18)21/h2-6,11-12H,7-10,13H2,1H3,(H,22,25)
- InChI Key
- ALAFUQJMXGKQAP-UHFFFAOYSA-N
- SMILES
- COc1cccc(CN2CCN(C(=O)Nc3ccc(Cl)cc3Cl)CC2)c1
- Source
- ZINC000017080518
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 26 | Ring Count | 3 |
Heteroatom Count | 7 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 44.81 Å2 | LogP | 4.053 |
LogS | -4.457 | LogD | 4.028 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.923 | Pgp substrate | 0.618 |
HIA | 0.966 | F20 % | 0.985 |
F30 % | 0.92 | Caco-2 | -4.589 |
MDCK | -4.648 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.615 | PPB | 99.033 |
VD | 1.671 | Fu | 1.647 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.013 | CYP1A2 substrate | 0.763 |
CYP2A6 substrate | 0.812 | CYP2B6 substrate | 0.62 |
CYP2C19 inhibitor | 0.977 | CYP2C19 substrate | 0.952 |
CYP2C8 substrate | 0.912 | CYP2C9 inhibitor | 0.79 |
CYP2C9 substrate | 0.323 | CYP2D6 inhibitor | 0.992 |
CYP2D6 substrate | 0.985 | CYP2E1 substrate | 0.868 |
CYP3A4 inhibitor | 0.683 | CYP3A4 substrate | 0.992 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.289 | CL | 9.601 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.997 | Hepatotoxicity | 0.716 |
Mutagenicity | 0.003 | Rat Oral Acute Toxicity | 0.674 |
FDAMDD | 0.366 | Skin Sensitization | 0.423 |
Carcinogenicity | 0.022 | Eye Corrosion | 0.002 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.947 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.919 | IGC50 | 3.972 |
LC50FM | 3.445 | LC50DM | -0.613 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.393 | NR-AR-LBD | 0.208 |
NR-AhR | 0.636 | NR-Aromatase | 0.035 |
NR-ER | 0.359 | NR-ER-LBD | 0.329 |
NR-PPAR-gamma | 0.175 | SR-ARE | 0.879 |
SR-ATAD5 | 0.397 | SR-HSE | 0.101 |
SR-MMP | 0.024 | SR-p53 | 0.176 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.